✦ LIBER ✦

Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myeloma

✍ Scribed by Gertz, M A; Kumar, S K; Lacy, M Q; Dispenzieri, A; Hayman, S R; Buadi, F K; Dingli, D; Gastineau, D A; Winters, J L; Litzow, M R

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictive factors for adequate hematopo

✍ M. Tomblyn; T. Rogers; M. Arora; J. Barker; C. Brunstein; L. Burns; D. Kaufman; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Stem Cells and Cancer Stem Cells, Volume

✍ Hayat, M.A. 📂 Article 📅 2012 🏛 Springer Netherlands ⚖ 287 KB

Risk-factors of melphalan/fludarabine do

✍ N. Kroger; J.A. Perez-Simon; H. Myint; H. Klingemann; A. Shimoni; A. Nagler; R. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 59 KB

High levels of serum angiogenic growth f

✍ Efstathios Kastritis; Maria Roussou; Michalis Michael; Maria Gavriatopoulou; Evr 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB

Timing of High Dose Melphalan (HDM) and

✍ A. Mahindra; B. Bolwell; L. Rybicki; R. Sobecks; B. Pohlman; S. Andresen; M. Ear 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 75 KB

International Myeloma Working Group guid

✍ Palumbo, A; Sezer, O; Kyle, R; Miguel, J S; Orlowski, R Z; Moreau, P; Niesvizky, 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 212 KB